Detalles de la búsqueda
1.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142371
2.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411939
3.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
4.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355464
5.
Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
BJU Int
; 123(1): 65-73, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29777564
6.
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Res Sq
; 2023 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36798177
7.
Accumulation of copy number alterations and clinical progression across advanced prostate cancer.
Genome Med
; 14(1): 102, 2022 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059000
8.
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 7(4): 555-563, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599706
9.
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison".
Eur Urol Oncol
; 3(4): 412-419, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591246
10.
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial.
JCO Precis Oncol
; 4: 882-897, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050761
11.
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
Eur Urol
; 76(6): 719-728, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31447077
12.
Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History.
Eur Urol
; 73(1): 92-93, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602204
Resultados
1 -
12
de 12
1
Próxima >
>>